Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Cancer. 2014 Nov 11;121(5):697–707. doi: 10.1002/cncr.29090

Figure 5. In ES patients with localized disease, serum NPY levels do not affect survival.

Figure 5

A. ES patients with localized disease were divided into four groups, based on serum NPY levels (above 75th percentile, 50th–75th percentile, 25th–50th percentile and below 25th percentile). Patients’ event-free survival (EFS) was compared between the groups using log-rank test. No significant differences between groups were detected. B. The same approach revealed no significant differences in overall survival between ES patients with various NPY levels.